Substandard and Falsified Medicines in Myanmar
<b>Background:</b> substandard and falsified medicines (SFMs) are a threat to public health. The availability of SFMs in Myanmar was reported by the World Health Organization (WHO) in 1999, but there have been few systematic surveys on falsified medicines in Myanmar since then. The aim o...
Main Authors: | Mirai Sakuda, Naoko Yoshida, Takashi Takaoka, Tomoko Sanada, Mohammad Sofiqur Rahman, Tsuyoshi Tanimoto, Theingi Zin, Kazuko Kimura, Hirohito Tsuboi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-03-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | https://www.mdpi.com/2226-4787/8/1/45 |
Similar Items
-
Substandard and falsified medicine screening technologies
by: Lukas Roth, et al.
Published: (2019-07-01) -
A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country
by: Daariimaa Khurelbat, et al.
Published: (2020-05-01) -
Usefulness of combined screening methods for rapid detection of falsified and/or substandard medicines in the absence of a confirmatory method
by: Kwabena Frimpong-Manso Opuni, et al.
Published: (2019-12-01) -
Impact of substandard and falsified antimalarials in Zambia: application of the SAFARI model
by: Kathryn D. Jackson, et al.
Published: (2020-07-01) -
Future Information Technology Tools for Fighting Substandard and Falsified Medicines in Low- and Middle-Income Countries
by: Huma Rasheed, et al.
Published: (2018-08-01)